Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD40L-binding agent based platelet aggregation assays

CD40L-binding agent based platelet aggregation assays

US Patent 9297810 · Granted Mar 29, 2016

Estimated economic value: $473,236,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for thei2023
Electronic system, portable electronic device and counting information updating 2023
Wearable electronic device and assembling method thereof2023
Recombinant intravenous immunoglobulin (rIVIG) compositions and methods for thei2022
Anti-BCMA antibodies2021
Electronic system, portable electronic device and counting information updating 2021
Anti-alpha synuclein binding molecules2019
Anti-alpha synuclein binding molecules2018
Anti-α synuclein binding molecules2017
Human control antibodies and uses therefor2016
Binding proteins, including antibodies, antibody derivatives and antibody fragme2016
Binding proteins, including antibodies, antibody derivatives and antibody fragme2016